1. Home
  2. TNGX vs NL Comparison

TNGX vs NL Comparison

Compare TNGX & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • NL
  • Stock Information
  • Founded
  • TNGX 2014
  • NL 1891
  • Country
  • TNGX United States
  • NL United States
  • Employees
  • TNGX N/A
  • NL N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • NL Major Chemicals
  • Sector
  • TNGX Health Care
  • NL Industrials
  • Exchange
  • TNGX Nasdaq
  • NL Nasdaq
  • Market Cap
  • TNGX 351.2M
  • NL 298.0M
  • IPO Year
  • TNGX N/A
  • NL N/A
  • Fundamental
  • Price
  • TNGX $6.01
  • NL $6.59
  • Analyst Decision
  • TNGX Strong Buy
  • NL Sell
  • Analyst Count
  • TNGX 6
  • NL 1
  • Target Price
  • TNGX $12.20
  • NL $6.00
  • AVG Volume (30 Days)
  • TNGX 2.7M
  • NL 71.0K
  • Earning Date
  • TNGX 08-06-2025
  • NL 08-06-2025
  • Dividend Yield
  • TNGX N/A
  • NL 5.48%
  • EPS Growth
  • TNGX N/A
  • NL 441.25
  • EPS
  • TNGX N/A
  • NL 1.25
  • Revenue
  • TNGX $40,990,000.00
  • NL $148,242,000.00
  • Revenue This Year
  • TNGX N/A
  • NL $15.75
  • Revenue Next Year
  • TNGX N/A
  • NL $2.44
  • P/E Ratio
  • TNGX N/A
  • NL $5.49
  • Revenue Growth
  • TNGX 10.09
  • NL N/A
  • 52 Week Low
  • TNGX $1.03
  • NL $5.21
  • 52 Week High
  • TNGX $12.02
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 76.36
  • NL 50.71
  • Support Level
  • TNGX $5.34
  • NL $6.35
  • Resistance Level
  • TNGX $6.40
  • NL $6.91
  • Average True Range (ATR)
  • TNGX 0.50
  • NL 0.45
  • MACD
  • TNGX -0.02
  • NL 0.08
  • Stochastic Oscillator
  • TNGX 84.08
  • NL 89.82

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: